Cell Source, Inc. (CLCS)
OTCMKTS: CLCS · Delayed Price · USD
0.580
+0.080 (16.00%)
Mar 27, 2024, 1:58 PM EDT - Market closed
Cell Source Market Cap
Cell Source has a market cap or net worth of $22.36 million as of March 28, 2024. Its market cap has decreased by -13.44% in one year.
Market Cap
22.36M
Enterprise Value
31.83M
1-Year Change
-13.44%
Ranking
n/a
Category
Stock Price
$0.58
Market Cap Chart
Since March 29, 2019, Cell Source's market cap has increased from $20.25M to $22.36M, an increase of 10.42%. That is a compound annual growth rate of 2.00%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 27, 2024 | 22.15M | 16.00% |
Mar 26, 2024 | 19.10M | -15.25% |
Mar 25, 2024 | 22.53M | - |
Mar 22, 2024 | 22.53M | - |
Mar 21, 2024 | 22.53M | 20.41% |
Mar 20, 2024 | 18.71M | 14.62% |
Mar 19, 2024 | 16.33M | 39.02% |
Mar 18, 2024 | 11.74M | -28.49% |
Mar 15, 2024 | 16.42M | 2.38% |
Mar 14, 2024 | 16.04M | 5.53% |
Mar 13, 2024 | 15.20M | -0.50% |
Mar 11, 2024 | 15.28M | 14.29% |
Mar 8, 2024 | 13.37M | -12.50% |
Mar 7, 2024 | 15.28M | - |
Mar 5, 2024 | 15.28M | - |
Mar 1, 2024 | 15.28M | - |
Feb 28, 2024 | 15.28M | - |
Feb 27, 2024 | 15.28M | 2.56% |
Feb 26, 2024 | 14.89M | -15.22% |
Feb 23, 2024 | 17.57M | 0.55% |
Feb 22, 2024 | 17.47M | 14.38% |
Feb 21, 2024 | 15.28M | - |
Feb 20, 2024 | 15.28M | 81.74% |
Feb 16, 2024 | 8.41M | -37.11% |
Feb 15, 2024 | 13.37M | -23.91% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly | 735.08B |
Novo Nordisk | 579.01B |
UnitedHealth Group | 450.04B |
Johnson & Johnson | 374.07B |
AbbVie | 316.43B |
Merck & Co. | 313.67B |
Thermo Fisher | 222.34B |
AstraZeneca | 205.55B |